Alpha 2.0
Login Register
» Authors » Paras B Mehta

Paras B Mehta

Explore the profile of Paras B Mehta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 30
Followers 0
Related Specialty
Endocrinology
Top 10 Co-Authors
Robert J Rushakoff
Michael A Kohn
Andrew Robinson
Rasmus Bennet
W Frank Peacock
Sanjeet G Patel
Ake Lernmark
Kelly R Keene
Suneil Koliwad
Ashok Balasubramanyam
Published In
BMJ Open Diabetes Res Care
J Diabetes Sci Technol
Curr Diab Rep
Endocr Pract
Diabetes
Affiliations
Soon will be listed here.
Recent Articles
1.
Novel Automated Self-adjusting Subcutaneous Insulin Algorithm Improves Glycemic Control and Physician Efficiency in Hospitalized Patients
Mehta P, Kohn M, Rov-Ikpah E, San Luis C, Johnson C, Lee G, et al.
J Diabetes Sci Technol . 2024 Mar; 18(3):541-548. PMID: 38454631
Background: Hyperglycemia occurs in 22% to 46% of hospitalized patients, negatively affecting patient outcomes, including mortality, inpatient complications, length of stay, and hospital costs. Achieving inpatient glycemic control is challenging...
2.
Inpatient glycemic control and community-acquired pneumonia outcomes in the pre-COVID-19 era: reviewing the evidence to pave the road for future studies
Mehta P, Gosmanov A
BMJ Open Diabetes Res Care . 2022 Jul; 10(4). PMID: 35790321
No abstract available.
3.
Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence
Mehta P, Robinson A, Burkhardt D, Rushakoff R
Endocr Pract . 2022 Jun; 28(9):884-888. PMID: 35753675
Objective: To identify clinical characteristics and factors associated with the development of euglycemic diabetic ketoacidosis (eDKA), and develop suitable strategies to reduce such events. Methods: Electronic health record (EHR) data...
4.
Lack of association between either outpatient or inpatient glycemic control and COVID-19 illness severity or mortality in patients with diabetes
Mehta P, Kohn M, Koliwad S, Rushakoff R
BMJ Open Diabetes Res Care . 2021 Jun; 9(1). PMID: 34059527
Introduction: To evaluate whether outpatient insulin treatment, hemoglobin A1c (HbA1c), glucose on admission, or glycemic control during hospitalization is associated with SARS-CoV-2 (COVID-19) illness severity or mortality in hospitalized patients...
5.
Metabolomics Profiling of Patients With A-β+ Ketosis-Prone Diabetes During Diabetic Ketoacidosis
Jahoor F, Hsu J, Mehta P, Keene K, Gaba R, Mulukutla S, et al.
Diabetes . 2021 May; 70(8):1898-1909. PMID: 34021044
When stable and near-normoglycemic, patients with "A-β+" ketosis-prone diabetes (KPD) manifest accelerated leucine catabolism and blunted ketone oxidation, which may underlie their proclivity to develop diabetic ketoacidosis (DKA). To understand...
6.
A Diabetes and COVID-19 Dilemma: Balancing Parents' Health & Children's Education
Mehta P, Rushakoff R
J Diabetes Sci Technol . 2020 Aug; 14(6):1129-1130. PMID: 32795089
No abstract available.
7.
SGLT2 Inhibitors and Cardiovascular Outcomes: Current Perspectives and Future Potentials
Jia X, Mehta P, Ye Y, Alam M, Birnbaum Y, Bajaj M
Curr Diab Rep . 2018 Jul; 18(9):63. PMID: 29995242
Purpose Of Review: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been shown to exert benefit on cardiac outcomes. In this review, we provide updates on available clinical data, studies on potential...